FibroGen (FGEN) Misses Q4 EPS by 13c

FibroGen (NASDAQ: FGEN) reported Q4 EPS of ($0.57), $0.13 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $27.1 million versus the consensus estimate of $38.78 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating